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Background: The prevention of type 2 diabetes is a recognised health care priority globally. Within the United
Kingdom, there is a lack of research investigating optimal methods of translating diabetes prevention programmes,
based on the promotion of a healthy lifestyle, into routine primary care. This study aims to establish the behavioural
and clinical effectiveness of a structured educational programme designed to target perceptions and knowledge of
diabetes risk and promote a healthily lifestyle, particularly increased walking activity, in a multi-ethnic population at
a high risk of developing type 2 diabetes.
Design: Cluster randomised controlled trial undertaken at the level of primary care practices. Follow-up will be
conducted at 12, 24 and 36 months. The primary outcome is change in objectively measured ambulatory activity.
Secondary outcomes include progression to type 2 diabetes, biochemical variables (including fasting glucose, 2-h
glucose, HbA1c and lipids), anthropometric variables, quality of life and depression.
Methods: 10 primary care practices will be recruited to the study (5 intervention, 5 control). Within each practice,
individuals at high risk of impaired glucose regulation will be identified using an automated version of the Leicester
Risk Assessment tool. Individuals scoring within the 90th percentile in each practice will be invited to take part in
the study. Practices will be assigned to either the control group (advice leaflet) or the intervention group, in which
participants will be invited to attend a 3 hour structured educational programme designed to promote physical
activity and a healthy lifestyle. Participants in the intervention practices will also be invited to attend annual group-
based maintenance workshops and will receive telephone contact halfway between annual sessions. The study will
run from 2010–2014.
Discussion: This study will provide new evidence surrounding the long-term effectiveness of a diabetes prevention
programme run within routine primary care in the United Kingdom.
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Overview
The high prevalence of type 2 diabetes mellitus wit-
nessed in the United Kingdom and globally represents
one of the greatest public health challenges in the 21st
century [1]. Currently, the treatment of diabetes
accounts for 7–14% of total health care spending across
low to high income regions of the globe and this is pro-
jected to increase in the future [2]. This has prompted
international and national health care organisations to
focus on prevention through targeted recommendations
and policy. In the United Kingdom, the NHS health
checks programme is aimed at screening all individuals
between 40 to 74 years of age for vascular and metabolic
disease risk and then treating high risk individuals ac-
cordingly [3]. Preventing type 2 diabetes is one of the
central aims of this programme. However in the UK,
translational research has lagged behind policy change
and there has been a lack of diabetes prevention pro-
grammes specifically developed for, and evaluated in,
routine health care settings. Therefore research pro-
grammes are urgently needed to address this need.
Physical activity and lifestyle in the prevention of type 2
diabetes
Type 2 diabetes is widely considered a lifestyle disease
because of its strong links to deleterious lifestyle prac-
tices associated with industrialisation. For example, it
has been shown that 80–90% of all cases of type 2 dia-
betes could be prevented through a healthy lifestyle
[4,5]. Furthermore, randomised controlled trials across
diverse countries and populations have shown that the
risk of progressing to type 2 diabetes in high risk popu-
lations can be reduced by up to 60% in those receiving
lifestyle interventions aimed at promoting moderate- to
vigorous-intensity physical activity along with a healthy
diet, and weight loss/maintenance [6]. The evidence
underpinning the link between physical activity and glu-
cose regulation is particularly compelling because it is
supported by the full spectrum of evidence needed to
infer causality, from observational research [7], to ex-
perimental mechanistic investigation [8], through to ran-
domised controlled trials [6,9]. The general importance
of physical activity to health was recently highlighted by
the World Health Organization who now rank physical
inactivity as the fourth leading cause of premature mor-
tality globally ahead of both obesity and dietary factors
[1].
Translation of research into practice
Lifestyle diabetes programmes with proven effectiveness
have used resource-intensive behaviour change strategies
involving multiple one-to-one patient contacts which are
incompatible with routine healthcare settings givencompeting health care needs and resource and infra-
structure limitations [10]. Therefore, diabetes prevention
pathways that are tailored to national and regional
health care systems need to be developed and evaluated.
Over the last decade, several countries including the
United States, Finland, Germany and Australia have met
this challenge by developing and evaluating diabetes pre-
vention pathways designed for routine clinical care [11].
Although undertaken in diverse settings, these transla-
tional programmes have tended to centre on group-
based health promotion programmes aimed at replicat-
ing the behavioural goals of gold standard research pro-
grammes [11]. However, despite these international
advances, there has been limited translational research
in the United Kingdom. This has consequently limited
the ability of primary care providers to commission
robust evidence-based diabetes prevention programmes.
In response to this need, we developed and evaluated a
brief structured education programme designed to pro-
mote increased walking activity and improved glucose
regulation in those at a high risk of type 2 diabetes as
identified through impaired glucose tolerance. This pro-
grammes was found to be highly effective at promoting
long-term changes to health behaviour and improve-
ments in glucose regulation [9,12]. The programme was
specially tailored to the needs and infrastructure avail-
able within primary care; this was achieved through
modelling the structure and educational philosophy on
an established and nationally available self-management
programme for those with diagnosed type 2 diabetes
[13]. Therefore the effectiveness of this approach at pro-
moting health behaviour and self-management skills in
the prevention of diabetes needs to be established within
a routine primary care setting.
Risk identification
In order to identify those who should be referred into a
prevention programme, it is also important to design
and evaluate pragmatic methods of identifying those
with a high risk of developing type 2 diabetes which can
be integrated into routine health care systems. Evaluated
diabetes prevention programmes have recruited those
with impaired glucose tolerance, commonly referred to
as prediabetes, identified through an oral glucose toler-
ance test (OGTT) [6,11]. This test incurs a substantial
burden to both health care professionals and patients
and is not routinely conducted or recommended as a
method of assessing diabetes risk. Risk scores, either in
conjunction with, or instead of, biochemical testing are
widely acknowledged as a pragmatic and effective way of
identifying risk status and their use is promoted by
European level guidance on the prevention of type 2 dia-
betes [14]. However, there is limited evidence from ran-
domised controlled trials to establish the clinical
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score who are likely to have a lower absolute risk of
developing diabetes and represent different characteris-
tics compared to those identified with impaired glucose
tolerance.
Study aim
The aim of the study is to establish whether a prag-
matic structured education programme with proven ef-
ficacy can promote health behaviour and improve
metabolic health in individuals at high risk of type 2
diabetes identified through a validated risk score in pri-
mary care.
Primary objective
 To investigate whether a lifestyle intervention
programme, based on a brief pragmatic education
programme with minimal ongoing support, can
promote sustained long-term increases in physical
activity in those identified with a high risk of type 2
diabetes in a primary health care setting.
Secondary objectives
 To investigate the impact of a lifestyle intervention
programme on glucose regulation, progression to type
2 diabetes and conventional cardiovascular risk
markers in those identified with a high risk of type 2
diabetes through a validated risk score
 To investigate the impact of a lifestyle intervention
programme on measures of quality of life and
depression in those with a high risk of type 2 diabetes
 To investigate the natural history of progression to
type 2 diabetes over a three year period in high risk
individuals identified through risk score technology.
Methods
Study design
This study is a clustered randomised controlled trial.
Randomization will be conducted at the level of the GP
practice by a trained individual who is independent of
the study team. Practices were randomised (1:1) to re-
ceive control conditions or a structured education
programme. A blocked design stratified for practice size
was used. The study is designed to adhere to inter-
nationally recognized criteria for developing complex
interventions [15] and for undertaking and reporting
cluster randomised controlled trials [16]. Follow-up will
be conducted at 12, 24 and 36 months in order to estab-
lish the longer-term effectiveness of the programme and
determine the natural history of progression to type 2
diabetes over three years in a high risk UK cohortidentified through a risk score in primary care. See
Figure 1 for a flow-diagram of the study design.
Sample size
This study was powered to detect a difference in change
in ambulatory activity of 2000 steps per day between
groups; a difference of this magnitude reflects the pri-
mary behaviour change aim of the intervention
programme and is consistent with the national physical
activity recommendations and the intervention effect
observed in the proof of concept study that preceded
this trial [9,17]. Previous studies with a follow-up of be-
tween 3 to 12 months have reported a standard devi-
ation of change in ambulatory activity of 2500–4000
steps per day in relevant populations [9,18-20]. There-
fore, in order to detect a difference of 2000 steps per day
between groups, assuming a standard deviation of 4000
steps per day, a power of 90%, a significance of 0.05, a
cluster size of 90 (see section titled Participants below)
and an intracluster correlation coefficient of 0.02 [21],
we require a minimum of 8 clusters. In order to account
for potential dropout at the practice level and comply
with guidance from the Medical Research Council for
minimum cluster numbers [22], 10 GP practice clusters
will be recruited to this trial.
This sample size will also have sufficient power to en-
able clinically significant differences to be detected
between groups for change in important secondary out-
comes. For example, based on a power of 80%, a signifi-
cance of 0.05 and a intracluster correlation coefficient of
0.02 [23], the above sample size will allow for a reduc-
tion in 2-h glucose of 0.8 mmol/l (based on a standard
deviation of 2 mmol/l standard deviation [24]) and a re-
duction in HbA1c of 0.2% (based on a standard devi-
ation a standard deviation of 0.5% [24,25]) to be
detected.
Participants
Ten GP practices will be recruited from the Leicestershire
region (city and county primary care trusts). Initial contact
with each GP practice will be through a letter of invitation
to take part. All recruited practices will have an induction
visit from the study co-ordinator who will provided training
and support for the administrative staff in each of the study
sites. Eligible participants will be identified using an auto-
mated version of Leicester Risk Assessment tool developed
and validated by our group [26]. The automated risk score
uses the Morbidity, Information Query and Export Syntax
(MIQUEST) programme, designed to extract data from
computerized medical records in primary care, to analyse
data from six variables (age, sex, ethnicity, BMI, family his-
tory of type 2 diabetes, antihypertensive medication status)
that are commonly held on local PCT databases. By assign-
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Figure 1 Design and flowchart for the walking away from type 2 diabetes study.
Yates et al. BMC Family Practice 2012, 13:46 Page 4 of 10
http://www.biomedcentral.com/1471-2296/13/46ranked by their risk of undiagnosed impaired glucose regu-
lation or type 2 diabetes with a higher score indicating
higher risk. The risk score is calculated as follows:
Risk factor Score = 0.0407 x age
+ 0.296 (if male, no change in female)
+ 0.934 (ethnicity, as a practice proportion of south
Asians)
+ 0.0859 x BMI
+ 0.440 (if family history of type 2 diabetes, no change
otherwise)
+ 0.374 (if on antihypertensive medication, no change
otherwise)
In this study, high risk individuals will be classified as
those above the 90th percentile of the calculated risk
score. Eligible individuals will be sent a letter of invita-
tion, a patient information sheet and stamped addressed
envelope by a member of their GP practice. Contacted
individuals will be requested to return a reply slip con-
firming or declining their interest in taking part; those
who wish to take part will be contacted by the study
team where a baseline consent appointment is arranged.
Individuals will be excluded from the study if they
have an existing diagnosis of type 2 diabetes or are diag-
nosed with type 2 diabetes at baseline, are taking ster-
oids or are unable to speak English; our experience
suggests this approach does not limit recruitment and is
able to produce a study population that fully reflects the
ethnic makeup of the local population.
Based on a typical GP practice of 4500 adults without
known type 2 diabetes, 450 will be eligible for inclusioninto the study based on the risk score. Of these we
anticipated that 330 (75%) will meet the initial inclusion
criteria and be invited to take part in the study. Around
100 (30%) are then expected to consent to take part, of
which 10 (10%) will have screen detected type 2 diabetes
and therefore excluded at baseline; therefore we antici-
pate the average cluster size to be 90 individuals (see
sample size calculation).
Those diagnosed with diabetes over the course of the
study will be informed of their diagnosis and referred back
to their health care team for standard care. Progression to
type 2 diabetes will be included as a secondary outcome.
Figure 1 shows the flow of the participants through
the study.Setting
The study is co-ordinated from the University Hospitals
of Leicester. However, clinical measurement sessions
and the educational programmes will be run in a variety
of different locations within the Leicestershire area, in-
cluding: hospital, primary care and community settings.
Locations that are as near as possible to the recruited
GP practices will be identified, including within the
practice itself where possible.Treatment regimens
Control
Control subjects will receive a booklet detailing informa-
tion on risk factors for type 2 diabetes and how physical
activity and lifestyle change can be used to prevent or
delay the disease. The leaflet addresses factors around
type 2 diabetes risk using the five domains (causes,
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highlighted by Leventhal’s common sense model [27].
Intervention
The intervention group will be offered the Walking
Away from Type 2 Diabetes group-based structured
educational programme. This programme is based on
the content and behaviour change techniques of the
successful Prediabetes Risk Education and Physical Ac-
tivity Recommendation and Encouragement (PRE-
PARE) programme; a full description of the rationale,
development and efficacy of which can be found else-
where [9,28]. Walking Away will be delivered to 6–10
individuals by two trained educators over 3 hours and
is primarily designed to promote walking activity by
targeting perceptions and knowledge of impaired glu-
cose tolerance and physical activity self-efficacy as well
as promoting self-regulatory skills such as goal-setting
strategies, self-monitoring, and relapse prevention
(identifying and addressing barriers to change). Self-
regulation is based around pedometer use, which has
been demonstrated to be crucial to the success of the
programme [9]. Specifically, those taking less than
6000 steps at baseline are encouraged to increase their
activity levels by at least 3000 steps per day, equivalent
to around 30 min of walking [29]. Those achieving
more than 6000 steps per day are encouraged to try
to reach at least 9000 steps per day, an amount that is
likely to include 30 min of walking activity in addition
to usual daily activity [29]. Those achieving more than
9000 steps per day are encouraged to at least maintain
their current activity levels and informed that health
benefits could be achieved by increasing their activity
levels further. Goal attainment is encouraged through
the use of proximal objectives. Participants are enabled
to set an action plan detailing where, when and how
their first proximal goal will be reached and encour-
aged to repeat this process for each new proximal
goal. Participants are encouraged to wear their pedom-
eter on a daily basis and to self-monitor their ambula-
tory activity using a steps-per-day log. Along with
physical activity, the programme has a specific section
dedicated to healthy dietary practices, particularly
around the identification and substitution of food
items high in saturated fat.
The programme content is underpinned by an inte-
grated theoretical framework, focused on linking motiv-
ational and volitional determinants of health behaviour.
The framework is based on mutually complementary
health behaviour theories, including Bandura’s social
cognitive theory [30], Gollwitzer’s implementation inten-
tions [31], Leventhal’s common sense model [27], and
Chaiken’s dual process theory [32] and was informed by,
and modelled on, the person-centred philosophy andlearning techniques developed for the DESMOND
programme [13]; a nationally available self-management
programme for those with type 2 diabetes run within
half of all PCTs nationally. The programme was devel-
oped inline with the Medical Research Council’s Frame-
work for Complex Interventions to Improve Health,
which are internationally recognised criteria for guiding
the development and evaluation of health behaviour
change programmes [15,33].
The walking Away programme was adapted for a
broader range of high risk individuals, such as those iden-
tified through a risk score, in order to make it suitable for
translation into usual healthcare practice. This necessi-
tated a shift in focus from the PREPARE programme,
which targeted illness perceptions around prediabetes, to
those associated with a more generic high risk label. In
order to meet this need, an additional section was added
to the programme that was aimed at communicating the
meaning of risk and risk status. Modifications to the PRE-
PARE programme were undertaken following an estab-
lished cyclic process that involved training a pool of
educators and then piloting the programme to a reprehen-
sive patient group whereupon patient and educator level
feedback were collected and the programme revised ac-
cordingly. This process was repeated twice.
Table 1 provides an overview of the programme con-
tent and structure.
Educator recruitment, training and quality assurance
A pool of around 10 educators will be recruited from
primary and secondary care and the community.
Those recruited from a health care setting will be
registered health care professionals and those from
the community will be required to process a degree
in a health science or be employed within a relevant
vocation (i.e. gym instructor). Educator training will
consist of two full core days followed by regular on-
going support. Training will be provided through fully
accredited national trainers for structured education
programmes hosted by the DESMOND collaborative.
In order to ensure that the programme philosophy
and content are adhered to, a quality assurance pro-
cedure was also developed based on established cri-
teria used within the DESMOND programme [34].
This involves an assessor sitting quietly and unobtru-
sively at the back of the room, with a CD playing
into a headphone whilst observing the programme.
The CD is silent, except for a beep sounding every
10 s. When the beep sounds, the assessor indicates
on a response sheet who is talking at that point (edu-
cator or participant), with other activity classed as
‘miscellaneous’ (silence, laughter or multiple conversa-
tions during learning activities) [34]. At the same
time the assessor fills in a prompt sheet indicating
Table 1 Outline of the Walking Away programme
Module Main aims Example activity Theoretical underpinning Time weighting
Introduction Welcome/housekeeping 5 minutes
Patient Story •Give participants a chance to
share their knowledge and
perceptions of being identified
as ‘at risk’ of type 2 diabetes and
highlight any concerns they may
want the programme to address.
•Participants are asked to share
their story, how they were
diagnosed as being ‘at risk’ of
developing type 2 diabetes and
their current knowledge of being
‘at risk’
•Common Sense Model [27] 25minutes
Professional story Use simple non-technical
language, analogies, visual aids
and open questions to provide
participants with:
•Individuals are helped to plot
their individual risk (fasting and 2
hour blood glucose levels,
cholesterol and blood pressure
levels - assessed at baseline)
•Common Sense Model [27] 35 minutes
•Dual Process Theory [32]
•An overview of healthy glucose
metabolism
•Social Cognitive Theory [30]
•The aetiology of diabetes
•An overview of the
macrovascular complications
associated with being ‘at risk’ of
type 2 diabetes.
Risk story •The meaning and assessment of
risk in the context of developing
type 2 diabetes
•Participants are supported to
plot their own risk factors onto a
risk chart to work out their
individual risk areas.
•Dual Process Theory [32] 25 minutes
•Social Cognitive Theory [30]
•Explore personal risk of
developing type 2 diabetes
Break Refreshments and informal
discussion
10 minutes
Physical activity Use simple non-technical
language, analogies, visual aids
and open questions to help
participants:
•Individuals are helped to plot
their individual steps per day
scores (assessed at baseline)
•Social Cognitive Theory [30] 55 minutes
•Implementation Intentions [31]
•Identify how physical activity
improves glucose control;
•Understand the current physical
activity recommendations
•Participants are provided with a
physical activity diary and
encouraged to set their first
action plan.•Explore options for incorporating
physical activity (primarily
walking) into everyday life
•Identify barriers to exercise
•Form action plans
•Use their provided physical
activity diaries
•Set personal goals (based on
baseline pedometer counts)
•Dual Process Theory [32]
Diet •Give participants an accurate
understanding of the link
between dietary macro-nutrients
and metabolic dysfunction
•Participants are asked to group
models of fats and oils into
saturated, polyunsaturated and
monounsaturated categories.
•Social Cognitive Theory [30] 20 minutes
•Dual Process Theory [32]
Conclusion Questions and future care Sign-post to locally available
groups/programmes
5 minutes
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ule were covered. All quality-assured educators re-
ceive feedback from their assessor and key goals and
action plans are developed in order to help the edu-
cator improve their performance.Follow-up support
After the participant’s annual clinical measurement ses-
sion, all individuals in the intervention group will be
invited to attend annual group-based sessions at 12 and
24 months in order to establish the impact of minimal
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follow-up programmes will be designed to help partici-
pants interpret and analyse their annual biochemical and
anthropometric follow-up data, review progress and
goals and respond to issues, queries and barriers; the
main objectives of the programme will also be rein-
forced. Each follow-up programme will last 2–3 h and
will be conducted by a trained educator. All participants
will also receive telephone contact between annual ses-




The primary end point will be ambulatory activity assessed
by tri-axial accelerometers (GT3X, Actigraph, FL, USA).
This outcome reflects the overall aim of the intervention
and is consistent with the fact that walking activity is the
preferred choice of activity within the population. Partici-
pants are asked to wear the accelerometer, fitted on their
trunks (placed on right anterior axillary line) with a waist-
band, for seven consecutive days during waking hours.
These accelerometers are one of the most extensively vali-
dated and accurate on the market and are the only com-
mercially available accelerometers to correlate with energy
expenditure as measured by double-labelled water [35].
Overall physical activity as defined by total body
movement (counts per day), and time in sedentary,
light-, moderate- and vigorous-intensity physical activity
will also be assessed by accelerometer and determined
by validated counts-per-minute cut-points [36].
Self-reported physical activity will also be measured
using the short last-seven-days self-administered format
of the International Physical Activity Questionnaire
(IPAQ). This questionnaire provides a comprehensive
measure of walking and other moderate- to vigorous-
intensity activities carried out for more than 10 continu-
ous minutes at work, in the home, as transport and dur-
ing leisure time. IPAQ has been shown to have
reasonable validity compared to accelerometer data
(ρ~0.4) and test-retest reliability (ρ~0.7) in the United
Kingdom when used as a measure of total moderate- to
vigorous-intensity physical activity [37]. For this study,
IPAQ will be used to measure total walking activity as
well as an overall measure of moderate- to vigorous-
intensity physical activity accumulated over all contexts.
All physical activity outcomes will be measured at
baseline and 12, 24 and 36 months.
Secondary outcomes
Biochemical variables
This study will measure relevant markers of metabolic
and renal health including fasting and 2-h post challenge
glucose, HbA1c, lipid profile, liver function tests(albumin, total bilirubin, alkaline phosphatase [ALP],
alanine transaminase [ALT]), urea and electrolytes (so-
dium, potassium, creatinine). Analysis is conducted in
the same laboratory located within Leicester Royal In-
firmary, UK, using stable methodology standardized to
external quality assurance reference values.
Participants will be invited to attend each clinical
measurement session after a 12-h fast and 24 h of avoid-
ing vigorous intensity exercise. In concordance with
WHO recommendations, those who have a fasting or 2-
h blood glucose level in the diabetes range at any clinical
measurement session will be called back for a confirma-
tory oral glucose tolerance test [38].
All venepuncture and OGTT timings will be under-
taken by trained phlebotomists who are not part of the
scientific advisory team for this study and who are
blinded to treatment allocation. All biochemical analysis
will also be conducted blinded to treatment group.
Anthropometric and demographic variables
Arterial blood pressure will be measured in the sitting
position (Omron, Healthcare, Henfield, UK); three mea-
surements will be obtained and the average of the last
two measurements will be used. Body weight and body
fat percentage (Tanita TBE 611, Tanita, West Drayton,
UK), waist circumference (midpoint between the lower
costal margin and iliac crest) and height will also be
measured, to the nearest 0.1 kg, 0.5% and 0.5 cm re-
spectively. Information on current smoking status, medi-
cation history, and ethnicity is obtained by self-report.
Social deprivation will be determined by assigning an
Index of Multiple Deprivation (IMD) score to participant
postcodes [39]. IMD scores are publicly available con-
tinuous measures of compound social and material
deprivation which are calculated using a variety of data
including current income, employment, health, educa-
tion, and housing.
Diet
Diet will be measured using the Dietary Instrument for
Nutrition Education (DINE) food frequency question-
naire, which was designed as a method of measuring
fibre, fat and unsaturated fat intake in primary care [40].
The DINE food frequency questionnaire has been shown
to have reasonable validity when assessed against food
records (0.45< r< 0.51) [40,41].
Health related quality of life
Health related quality of life will be measured by the
15D instrument, which can be used as a profile or a sin-
gle index score utility measure [42]. It consists of 15
dimensions: mobility, vision, hearing, breathing, sleep-
ing, eating, speech, elimination, usual activities, mental
function, discomfort and symptoms, depression, distress,
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into five ordinal levels, by which more or less of the at-
tribute can be distinguished. The valuation system of the
15D is based on an application of the multi-attribute
utility theory. A difference of ≥0.03 in the 15D single
index score utility score is considered clinically import-
ant [42].
Perceptions and perceived knowledge of diabetes risk
Perceptions and perceived knowledge of diabetes risk
will be measured with the validated brief illness percep-
tions questionnaire [43]. This eight item instrument uses
an 11 point Likert scale (0 = no effect, 10 = complete ef-
fect) to measure five cognitive illness representations
(consequences, timeline, personal control, treatment
control, and identity), two emotional representations
(concern and emotion) and illness comprehensibility
(perceived knowledge). The brief illness perception ques-
tion provides a practical and comprehensive measure-
ment of determinants identified in Leventhal’s common
sense model [27], one of the key theoretical models
underpinning the content and structure of the education
programme.
Depression and anxiety
Depression and anxiety will be measured with the Hos-
pital Anxiety and Depression Scale (HADS) [44]. HADS
consists of 14 items, with two sub-scales measuring
symptoms of depression and symptoms of anxiety.
HADS is widely used and has been shown to perform
well in primary care [45].
Data analysis
The study will be reported according to the internation-
ally recognised CONSORT statement for the reporting
of cluster randomised control trials [16]. Those with-
drawn from the study due to a diagnosis of type 2 dia-
betes will have their last observation carried forward.
Sensitivity analysis, using multiple imputation, will be
used to assess the effect of those missing to follow-up.
Random effects regression models, controlled for base-
line value and taking into account cluster, will be used
to look at the difference between groups in change from
baseline in continuous outcome measures after checking
for normality and applying transformation techniques
where necessary. Extreme outliers (more than 4 standard
deviations from the mean) will be removed from the
analysis. Survival curves will be calculated to estimate
the cumulative incidence of diabetes. The difference in
incidence of diabetes in the groups will be tested using
the two-sided log-rank test. Statistical significance will be
assessed at the 5% level and all analysis will be 2-sided.
Interim analysis will be conducted and reported at
12 months.In concordance with other physical activity rando-
mised controlled trials undertaken by our group and
others [46,47], we will undertake pooled analysis of the
study cohort to determine, through regression analysis
techniques, the extent to which change in physical activ-
ity is associated with change in key biochemical and an-
thropometric variables; this will help provide additional
information quantifying the strength of the association
between physical activity and metabolic health in a
population with a high risk of type 2 diabetes; any such
analysis will be reported with the caveats inherent in
undertaking additional pooled cohort analysis within the
context of a randomised controlled trial.Current status
This study gained full ethical and governance approvals
from the Nottingham Research Ethics Committee 2 and
the Leicestershire, Northamptonshire and Rutland Com-
prehensive Local Research network in April 2009. Re-
cruitment of patients was initiated in 2010.Discussion
To our knowledge this will be the first study in the Uni-
ted Kingdom to establish the long-term effectiveness of
an intervention programme designed to promote life-
style change in those with a high risk of type 2 diabetes
identified using a risk score within primary care. Whilst
both the effectiveness and cost-effectiveness of lifestyle
intervention programmes at preventing type 2 diabetes
have been established [6,48], there has been a lack of
translational research aimed at developing and evaluat-
ing a diabetes prevention programmes specifically
designed for a routine health care setting in the UK.
This has limited the ability of health care commissioners
and policy makers to make informed evidence-based
decisions regarding the implementation of regional and
national diabetes prevention programmmes. This study
will help address this limitation.
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